Infliximab associated new-onset psoriasis.
Infliximab infusion is not yet FDA-approved for psoriasis but has been reported to be very effective for plaque psoriasis. We report 2 patients without a history of psoriasis who after administration of infliximab for their inflammatory bowel disease experienced new onset, biopsy confirmed psoriasis.
Adams
David R
DR
Penn State Hershey Medical Center, Department of Dermatology, Hershey, PA 17033, USA. dadams@psu.edu
Buckel
Tamy
T
Sceppa
Jennifer A
JA
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003879:Dermatologic Agents / Q000009:adverse effects*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy; D000069285:Infliximab; D008297:Male; D011565:Psoriasis / Q000139:chemically induced*
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab